BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8531140)

  • 1. Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea and tracers in the rabbit brain after interstitial delivery by biodegradable polymer implants.
    Strasser JF; Fung LK; Eller S; Grossman SA; Saltzman WM
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1647-55. PubMed ID: 8531140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers.
    Grossman SA; Reinhard C; Colvin OM; Chasin M; Brundrett R; Tamargo RJ; Brem H
    J Neurosurg; 1992 Apr; 76(4):640-7. PubMed ID: 1545259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain.
    Fung LK; Ewend MG; Sills A; Sipos EP; Thompson R; Watts M; Colvin OM; Brem H; Saltzman WM
    Cancer Res; 1998 Feb; 58(4):672-84. PubMed ID: 9485020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
    Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
    J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors.
    Sampath P; Hanes J; DiMeco F; Tyler BM; Brat D; Pardoll DM; Brem H
    Cancer Res; 1999 May; 59(9):2107-14. PubMed ID: 10232596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer.
    Yang MB; Tamargo RJ; Brem H
    Cancer Res; 1989 Sep; 49(18):5103-7. PubMed ID: 2766281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain.
    Fung LK; Shin M; Tyler B; Brem H; Saltzman WM
    Pharm Res; 1996 May; 13(5):671-82. PubMed ID: 8860421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain.
    Domb AJ; Rock M; Perkin C; Yipchuck G; Broxup B; Villemure JG
    Biomaterials; 1995 Sep; 16(14):1069-72. PubMed ID: 8519927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
    Ewend MG; Williams JA; Tabassi K; Tyler BM; Babel KM; Anderson RC; Pinn ML; Brat DJ; Brem H
    Cancer Res; 1996 Nov; 56(22):5217-23. PubMed ID: 8912860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.
    Brem H; Tamargo RJ; Olivi A; Pinn M; Weingart JD; Wharam M; Epstein JI
    J Neurosurg; 1994 Feb; 80(2):283-90. PubMed ID: 8283268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
    Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H
    Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.
    Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H
    Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the carmustine implant.
    Fleming AB; Saltzman WM
    Clin Pharmacokinet; 2002; 41(6):403-19. PubMed ID: 12074689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy.
    Wu MP; Tamada JA; Brem H; Langer R
    J Biomed Mater Res; 1994 Mar; 28(3):387-95. PubMed ID: 8077254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of [3H]dexamethasone in rat subcutaneous tissue after delivery from osmotic pumps.
    Moussy Y; Hersh L; Dungel P
    Biotechnol Prog; 2006; 22(3):819-24. PubMed ID: 16739966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic disposition and elimination studies of a radiolabelled biodegradable polymeric implant in the rat brain.
    Domb AJ; Rock M; Schwartz J; Perkin C; Yipchuk G; Broxup B; Villemure JG
    Biomaterials; 1994 Jul; 15(9):681-8. PubMed ID: 7948590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gliadel wafers for treatment of brain tumors.
    Med Lett Drugs Ther; 1998 Sep; 40(1035):92. PubMed ID: 9760950
    [No Abstract]   [Full Text] [Related]  

  • 18. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
    Yuan X; Tabassi K; Williams JA
    Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The delivery of BCNU to brain tumors.
    Wang CC; Li J; Teo CS; Lee T
    J Control Release; 1999 Aug; 61(1-2):21-41. PubMed ID: 10469900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
    Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
    Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.